News & Updates
Filter by Specialty:
Doxycycline, meningo vax reduce STI incidence among MSM on PrEP
Use of doxycycline as postexposure prophylaxis (PEP) results in a significant decrease in the incidence of Chlamydia trachomatis (CT) and syphilis and demonstrates a significant impact on the incidence of Neisseria gonorrhoeae (GC), reports a study presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI). Meningococcal B vaccine also helps lower the incidence of GC.
Doxycycline, meningo vax reduce STI incidence among MSM on PrEP
28 Feb 2023PrEP use tied to ‘stable’ STI incidence, sexual behaviour among MSM
The incidence of sexually transmitted infection (STI) over the first 4 years of pre-exposure prophylaxis (PrEP) use remains high and stable, but the incidence of chlamydia and gonorrhea has slightly decreased among daily PrEP users, as shown in a study presented at the 30th Conference on Retroviruses and Opportunistic Infections (CROI).
PrEP use tied to ‘stable’ STI incidence, sexual behaviour among MSM
27 Feb 2023FMT prevents recurrent C. difficile infection in IBD patients
Patients with inflammatory bowel disease (IBD) who undergo foecal microbiota transplantation (FMT) are less likely to develop recurrent Clostridioides difficile infection (CDI), a study has shown.
FMT prevents recurrent C. difficile infection in IBD patients
23 Feb 2023Alcohol intake tied to lower H. pylori infection risk, with caveat
A recent meta-analysis has revealed a decreased risk of Helicobacter pylori infection among alcohol drinkers as compared with nondrinkers, with wine and mixed types of alcohol showing greater infection reduction than beer.
Alcohol intake tied to lower H. pylori infection risk, with caveat
22 Feb 2023VV116 noninferior to nirmatrelvir-ritonavir for COVID-19
Early administration of oral VV116 was noninferior to nirmatrelvir-ritonavir in shortening the time to sustained clinical recovery in individuals with mild-to-moderate COVID-19 who were at high risk for progression to severe disease, a phase III trial has shown. VV116 also had fewer safety issues than nirmatrelvir-ritonavir.
VV116 noninferior to nirmatrelvir-ritonavir for COVID-19
21 Feb 2023Is adjunctive vitamin C beneficial to critically ill patients with COVID-19?
Use of adjunctive intravenous (IV) vitamin C for the management of critically ill patients with COVID-19 infection does not achieve the desired outcome of a reduction in the incidence of mortality, vasopressor requirements, Sequential Organ Failure Assessment (SOFA) scores, or ventilator settings, reports a study.
Is adjunctive vitamin C beneficial to critically ill patients with COVID-19?
20 Feb 2023Rising cases of community-acquired E. coli UTI in children a cause for concern
A recent study has found an increasing prevalence of community-acquired (CA) urinary tract infection (UTI) by emerging spectrum-β-lactamase-producing (ESBL) E. coli in children, with most isolates showing resistance to multiple drugs.
Rising cases of community-acquired E. coli UTI in children a cause for concern
18 Feb 2023Counselling, pamphlets boost flu vaccine intake in SG
Use of educational pamphlets alone and individualized counselling (IC) both lead to improved uptake of influenza vaccination, reports a Singapore study, noting that IC is not superior to pamphlets alone in increasing uptake.